Connection
Robert MacLaren to Adrenergic alpha-2 Receptor Agonists
This is a "connection" page, showing publications Robert MacLaren has written about Adrenergic alpha-2 Receptor Agonists.
|
|
Connection Strength |
|
 |
|
 |
|
0.558 |
|
|
|
-
Preslaski CR, Mueller SW, Wempe MF, MacLaren R. Stability of dexmedetomidine in polyvinyl chloride bags containing 0.9% sodium chloride injection. Am J Health Syst Pharm. 2013 Aug 01; 70(15):1336-41.
Score: 0.437
-
Reynolds PM, Mueller SW, MacLaren R. A comparison of dexmedetomidine and placebo on the plasma concentrations of NGF, BDNF, GDNF, and epinephrine during severe alcohol withdrawal. Alcohol. 2015 Feb; 49(1):15-9.
Score: 0.121